Zymeworks Inc.
ZYME · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.93 | 3.07 | 0.58 |
| FCF Yield | -1,758.25% | 1.18% | -0.38% | -3.77% |
| EV / EBITDA | 2.02 | 334.20 | -37.52 | -75.37 |
| Quality | ||||
| ROIC | -5.71% | -0.20% | -7.14% | -7.72% |
| Gross Margin | 0.00% | 100.00% | 100.00% | 88.11% |
| Cash Conversion Ratio | 1.60 | 5.21 | 0.15 | 1.77 |
| Growth | ||||
| Revenue 3-Year CAGR | -33.71% | -35.01% | -40.63% | -43.02% |
| Free Cash Flow Growth | -203,458.35% | 426.88% | 91.82% | 99.94% |
| Safety | ||||
| Net Debt / EBITDA | 2.08 | -30.71 | 2.59 | 3.38 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 3.96 | -60.58 | 175.02 |